Li Meng 4

What Happened Li Meng, Interim CEO of Avalon GloboCare Corp. (ALBT), was granted a derivative award covering 400,000 shares on 2026-06-29. The Form 4 reports the acquisition price as $0.00 (derivative security); a footnote states 100% of the shares subject to the option vest in full on the grant date. This was an award/grant of derivative securities (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-06-29; filing date: 2026-07-13 (filed late relative to the usual 2-business-day Form 4 deadline).
• Reported acquisition: 400,000 shares (derivative) at $0.00 per share; reported value shown as $0.
• Vesting: Footnote F1 — 100% of the shares subject to the option vested in full on the grant date.
• Shares owned after transaction: Not specified in this Form 4.
• Filing timeliness: Marked late (transaction reported ~2 weeks after the grant).

Context This filing documents a company grant of derivative securities (an option-like award) that vested immediately. It is not a sale or a market purchase and does not indicate that shares were sold. Awards to executives are common as compensation; because this is a grant and the filing was late, investors should note the timing but avoid assuming intent beyond the disclosed compensation action.